Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Rhythm: Medications and technologies that could transform cardiology | The value of cardiac MRI
Tuesday, March 15, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

4 new medications and technologies that could transform cardiology in 2022

The FDA has already approved one of the medications, with a decision on another expected by the end of April. 

READ MORE >
The LDL-lowering medication inclisiran (Leqvio) was recently cleared by the FDA. It used only two doses per year. It was included it the Cleveland Clinic annual list of the top 10 medical innovations expected to make a big impact on patient care in 2022.
Share on Twitter Share on Facebook Share on Linkedin

4 new medications and technologies that could transform cardiology in 2022

Share on Twitter Share on Facebook Share on Linkedin
The LDL-lowering medication inclisiran (Leqvio) was recently cleared by the FDA. It used only two doses per year. It was included it the Cleveland Clinic annual list of the top 10 medical innovations expected to make a big impact on patient care in 2022.
The FDA has already approved one of the medications, with a decision on another expected by the end of April. 
READ MORE >

AFib, AI and heart-healthy diets: European Society of Cardiology previews EHRA 2022

The European Heart Rhythm Association's annual conference is headed to Denmark. 

READ MORE >
EHRA 2022, the yearly get-together hosted by the European Heart Rhythm Association (EHRA), is scheduled for April 3-5 at the Bella Center in Copenhagen, Denmark. European Society of Cardiology
Share on Twitter Share on Facebook Share on Linkedin

AFib, AI and heart-healthy diets: European Society of Cardiology previews EHRA 2022

Share on Twitter Share on Facebook Share on Linkedin
EHRA 2022, the yearly get-together hosted by the European Heart Rhythm Association (EHRA), is scheduled for April 3-5 at the Bella Center in Copenhagen, Denmark. European Society of Cardiology
The European Heart Rhythm Association's annual conference is headed to Denmark. 
READ MORE >

Cardiac MRI a powerful tool for predicting sudden cardiac death, arrhythmia after CIED implantation

The study's authors suspect their findings could improve patient selection for CIEDs. 

READ MORE >
A new artificial intelligence tool can detect heart disease on cardiovascular MRI scans in seconds with equal or superior precision as clinicians. 
Share on Twitter Share on Facebook Share on Linkedin

Cardiac MRI a powerful tool for predicting sudden cardiac death, arrhythmia after CIED implantation

Share on Twitter Share on Facebook Share on Linkedin
A new artificial intelligence tool can detect heart disease on cardiovascular MRI scans in seconds with equal or superior precision as clinicians. 
The study's authors suspect their findings could improve patient selection for CIEDs. 
READ MORE >

AI-powered ECG analysis could boost care for patients with hypertrophic cardiomyopathy

Advanced algorithms can pick up on key details in a 12-lead ECG that human readers are unable to see. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI-powered ECG analysis could boost care for patients with hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
Advanced algorithms can pick up on key details in a 12-lead ECG that human readers are unable to see. 
READ MORE >

DOACs an effective substitute for VKAs after AFib patients undergo bioprosthetic valve replacement

Direct oral anticoagulants are noninferior to vitamin K antagonists when treating this important patient population, researchers reported. 

READ MORE >
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Share on Twitter Share on Facebook Share on Linkedin

DOACs an effective substitute for VKAs after AFib patients undergo bioprosthetic valve replacement

Share on Twitter Share on Facebook Share on Linkedin
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Direct oral anticoagulants are noninferior to vitamin K antagonists when treating this important patient population, researchers reported. 
READ MORE >

Screening older patients for AFib during regular care is feasible, but not productive

Screening did provide some value for patients 85 years and older, but more research is still required. 

READ MORE >
ECG rhythm strip from a 6-lead ECG
Share on Twitter Share on Facebook Share on Linkedin

Screening older patients for AFib during regular care is feasible, but not productive

Share on Twitter Share on Facebook Share on Linkedin
ECG rhythm strip from a 6-lead ECG
Screening did provide some value for patients 85 years and older, but more research is still required. 
READ MORE >

CRT-D associated with major improvements among older HFrEF patients

The study's authors said CRT use among older patients represents a "major gap in knowledge." 

READ MORE >
Cardiac resynchronization therapy with a defibrillator (CRT-D) can be used to significantly improve mortality and hospitalization rates among older heart failure patients. CRT-D illustration courtesy of Boston Scientific.
Share on Twitter Share on Facebook Share on Linkedin

CRT-D associated with major improvements among older HFrEF patients

Share on Twitter Share on Facebook Share on Linkedin
Cardiac resynchronization therapy with a defibrillator (CRT-D) can be used to significantly improve mortality and hospitalization rates among older heart failure patients. CRT-D illustration courtesy of Boston Scientific.
The study's authors said CRT use among older patients represents a "major gap in knowledge." 
READ MORE >

Electrophysiologists debut new technology that builds interactive cardiac maps out of 12-lead ECGs

The solution, which gained FDA clearance in November 2021, is now being used by specialists at the University of California San Diego Health.

READ MORE >
The Vektor Medical vMap system takes standard 12-lead ECGs and converts them into detailed electro anatomical maps for us in catheter ablation procedures.
Share on Twitter Share on Facebook Share on Linkedin

Electrophysiologists debut new technology that builds interactive cardiac maps out of 12-lead ECGs

Share on Twitter Share on Facebook Share on Linkedin
The Vektor Medical vMap system takes standard 12-lead ECGs and converts them into detailed electro anatomical maps for us in catheter ablation procedures.
The solution, which gained FDA clearance in November 2021, is now being used by specialists at the University of California San Diego Health.
READ MORE >

FDA expands two Medtronic cardiac cryoablation catheters for AVNRT

The two single-use devices are now approved for the treatment of pediatric AVNRT.

READ MORE >
The FDA has cleared Medtronic's Freezor and Freezor Xtra cardiac cryoablation catheters for the treatment of pediatric atrioventricular nodal reentrant tachycardia (AVNRT).
Share on Twitter Share on Facebook Share on Linkedin

FDA expands two Medtronic cardiac cryoablation catheters for AVNRT

Share on Twitter Share on Facebook Share on Linkedin
The FDA has cleared Medtronic's Freezor and Freezor Xtra cardiac cryoablation catheters for the treatment of pediatric atrioventricular nodal reentrant tachycardia (AVNRT).
The two single-use devices are now approved for the treatment of pediatric AVNRT.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme